Article Details

Around the Practice: Relapsed/Refractory HER2+ Metastatic Breast Cancer

Retrieved on: 2021-04-22 15:56:15

Tags for this article:

Click the tags to see associated articles and topics

Around the Practice: Relapsed/Refractory HER2+ Metastatic Breast Cancer. View article details on hiswai:

Excerpt

... the HER2-targeted monoclonal antibodies trastuzumab and pertuzumab. ... docetaxel is appropriate in combination with a HER2-targeted antibody.

Article found on: www.cancernetwork.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up